150 related articles for article (PubMed ID: 37076508)
1. A novel immune score model predicting the prognosis and immunotherapy response of breast cancer.
Lv W; He X; Wang Y; Zhao C; Dong M; Wu Y; Zhang Q
Sci Rep; 2023 Apr; 13(1):6403. PubMed ID: 37076508
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
Front Immunol; 2022; 13():891175. PubMed ID: 35990668
[TBL] [Abstract][Full Text] [Related]
3. A Novel Inflammatory Response-Related Gene Signature Predicts Immune Status and Prognosis of Breast Cancer.
Zhao R; Xie C; Gong Y; Wei S; Yuan M; Gan J; Chen W
J Oncol; 2022; 2022():5468858. PubMed ID: 36467500
[TBL] [Abstract][Full Text] [Related]
4. Landscape of prognosis and immunotherapy responsiveness under tumor glycosylation-related lncRNA patterns in breast cancer.
Lv W; Tan Y; Zhou X; Zhang Q; Zhang J; Wu Y
Front Immunol; 2022; 13():989928. PubMed ID: 36189319
[TBL] [Abstract][Full Text] [Related]
5. Exploring the role of sphingolipid-related genes in clinical outcomes of breast cancer.
Pei S; Zhang P; Yang L; Kang Y; Chen H; Zhao S; Dai Y; Zheng M; Xia Y; Xie H
Front Immunol; 2023; 14():1116839. PubMed ID: 36860848
[TBL] [Abstract][Full Text] [Related]
6. Establishment and validation of an aging-related risk signature associated with prognosis and tumor immune microenvironment in breast cancer.
Wang Z; Liu H; Gong Y; Cheng Y
Eur J Med Res; 2022 Dec; 27(1):317. PubMed ID: 36581948
[TBL] [Abstract][Full Text] [Related]
7. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
Front Genet; 2022; 13():919389. PubMed ID: 35783281
[No Abstract] [Full Text] [Related]
8. Development of a Novel Immune-Related Gene Prognostic Index for Breast Cancer.
Yao Y; Kong X; Liu R; Xu F; Liu G; Sun C
Front Immunol; 2022; 13():845093. PubMed ID: 35558081
[TBL] [Abstract][Full Text] [Related]
9. Development of a prognostic signature based on immune-related genes and the correlation with immune microenvironment in breast cancer.
Dong M; Cui X; Wang G; Zhang Q; Li X
Aging (Albany NY); 2022 Jul; 14(13):5427-5448. PubMed ID: 35793235
[TBL] [Abstract][Full Text] [Related]
10. Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis.
Zhang Z; Shen X; Tan Z; Mei Y; Lu T; Ji Y; Cheng S; Xu Y; Wang Z; Liu X; He W; Chen Z; Chen S; Lv Q
Front Genet; 2022; 13():1053263. PubMed ID: 36712869
[No Abstract] [Full Text] [Related]
11. An exosome-related long non-coding RNAs risk model could predict survival outcomes in patients with breast cancer.
Qiu P; Guo Q; Lin J; Pan K; Chen J; Ding M
Sci Rep; 2022 Dec; 12(1):22322. PubMed ID: 36566321
[TBL] [Abstract][Full Text] [Related]
12. A Novel Aging-Related Prognostic lncRNA Signature Correlated with Immune Cell Infiltration and Response to Immunotherapy in Breast Cancer.
Liu Z; Ren C; Cai J; Yin B; Yuan J; Ding R; Ming W; Sun Y; Li Y
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110517
[TBL] [Abstract][Full Text] [Related]
13. Necroptosis-related lncRNA to establish novel prognostic signature and predict the immunotherapy response in breast cancer.
Chen F; Yang J; Fang M; Wu Y; Su D; Sheng Y
J Clin Lab Anal; 2022 Apr; 36(4):e24302. PubMed ID: 35229919
[TBL] [Abstract][Full Text] [Related]
14. Identification and development of an independent immune-related genes prognostic model for breast cancer.
Chen L; Dong Y; Pan Y; Zhang Y; Liu P; Wang J; Chen C; Lu J; Yu Y; Deng R
BMC Cancer; 2021 Mar; 21(1):329. PubMed ID: 33785008
[TBL] [Abstract][Full Text] [Related]
15. Identification of cuproptosis-related long noncoding RNA signature for predicting prognosis and immunotherapy response in bladder cancer.
Huang G; Huang Y; Zhang C; Jiang Y; Ye Z; He C; Yu F; Chen Z; Xi X
Sci Rep; 2022 Dec; 12(1):21386. PubMed ID: 36496537
[TBL] [Abstract][Full Text] [Related]
16. Identification of a combined apoptosis and hypoxia gene signature for predicting prognosis and immune infiltration in breast cancer.
Ren X; Cui H; Wu J; Zhou R; Wang N; Liu D; Xie X; Zhang H; Liu D; Ma X; Dang C; Kang H; Lin S
Cancer Med; 2022 Oct; 11(20):3886-3901. PubMed ID: 35441810
[TBL] [Abstract][Full Text] [Related]
17. A novel hypoxia- and lactate metabolism-related signature to predict prognosis and immunotherapy responses for breast cancer by integrating machine learning and bioinformatic analyses.
Li J; Qiao H; Wu F; Sun S; Feng C; Li C; Yan W; Lv W; Wu H; Liu M; Chen X; Liu X; Wang W; Cai Y; Zhang Y; Zhou Z; Zhang Y; Zhang S
Front Immunol; 2022; 13():998140. PubMed ID: 36275774
[TBL] [Abstract][Full Text] [Related]
18. Immune-Related Genes' Prognostic, Therapeutic and Diagnostic Value in Ovarian Cancer Immune-Related Gene Biomarker in Ovarian Cancer.
Ding B; Yan W; Shen S; Meng D; Chen X; Wang S; Shen Y
Cancer Control; 2023; 30():10732748231168756. PubMed ID: 37078136
[TBL] [Abstract][Full Text] [Related]
19. A novel immune-related prognostic index for predicting breast cancer overall survival.
Yu X; Guo J; Zhou Q; Huang W; Xu C; Long X
Breast Cancer; 2021 Mar; 28(2):434-447. PubMed ID: 33146847
[TBL] [Abstract][Full Text] [Related]
20. A tumor microenvironment-related risk model for predicting the prognosis and tumor immunity of breast cancer patients.
Geng S; Fu Y; Fu S; Wu K
Front Immunol; 2022; 13():927565. PubMed ID: 36059555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
